Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam for Postoperative Pain After Laparoscopic Cholecystectomy
NCT04622813Phase 3Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Apr 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nefopam in postoperative pain (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Total morphine consumption in the post anesthesia care unit. Started Apr 2021; status: completed.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04622813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622813.